Lupin launches generic drug used for prevention of organ rejection in kidney transplant in US

Drug firm Lupin on Monday said it has launched generic Mycophenolic
acid delayed-release tablets, which is used to prevent organ rejection
in patients receiving kidney transplants in the US market.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupin-launches-generic-drug-used-for-prevention-of-organ-rejection-in-kidney-transplant-in-us/articleshow/75006474.cms